David Meline Elected As An Independent Board Member By Lonza

The Board of Directors at Lonza’s today announced David Meline, a nominee for Independent Member of the Board. His nomination will be presented to shareholders for approval at the company's Annual General Meeting (AGM) in May 2025. David Meline has served as a CFO (Chief Financial Officer) in more than two publicly traded industries and significant biotech companies. He has also been a part of various capital-intensive firms throughout his career. During the COVID-19 pandemic, David even served as a CFO at Moderna. 

David has previously served as both Chief Financial Officer and Chief Accounting Officer at 3M Company. His career also includes over two decades at General Motors, where he held the role of regional CFO, overseeing financial operations on five continents. He also led the finance business and IT services of the world's largest biotech companies, such as Amgen. 

David is a board member at HP Inc., Pacific Biosciences of California, Inc., and ABB Ltd., where he leads the Finance, Audit, and Compliance Committee as Chairman. Olivier Verscheure has voluntarily decided not to take part in the election at the Annual General Meeting in May 2025. Olivier has been a member of the Innovation & technology committee and the board since 2018. 

Olivier has brought valuable digital expertise to Lonza as a Professor of Computer Science at EPFL (ETH Lausanne), and the Co-Founder & Executive Director of the Swiss Data Science Center, (National hub for applied AI & Data Science). The Board has even expressed their gratitude towards him for his significant contributions over the years.

Jean-Marc Huët, Board Chairman, Lonza, said in a statement, “The Board of Directors is delighted to nominate David for election to the Board. David brings a wealth of board experience alongside an outstanding track record of driving growth and innovation as the CFO of global industrial and pharma companies. His deep industry knowledge, finance, and IT experience will be invaluable assets to Lonza as we focus on structured growth, customer delivery, and innovation. I would also like to take this opportunity to pay tribute to Olivier for his extensive contributions to our board and business.”